Submit your comments on this article |
Science & Technology |
Israel says signed MOU with NRX Pharmaceuticals for COVID vaccine trials |
2021-07-12 |
[YNet] - Israel has signed a memorandum of understanding with NRX Pharmaceuticals to complete trials and commercialize the Israeli-developed COVID-19 vaccine BriLife, the Defense Ministry said on Monday. The vaccine was developed by the Israel Institute for Biological Research, which is overseen by the Defense Ministry. Because if one needs a booster shot every few months, Pfizer becomes, just a tad, too expensive. Also, there should be a large market in countries currently using Sinodreck. |
Posted by:g(r)omgoru |
#1 Useful to have your own research center the next time something interesting escapes from China, so you don’t have to wait for the usual players accept you as a secondary customer. |
Posted by: trailing wife 2021-07-12 14:43 |